{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "shortName": "DBV TECHNOLOGIES SA DBV TECHNOL", "exchangeTimezoneShortName": "BST", "market": "gb_market", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "exchange": "IOB", "longName": "DBV Technologies S.A.", "regularMarketChangePercent": 1.1944807, "regularMarketPrice": 3.304, "exchangeTimezoneName": "Europe/London", "marketState": "CLOSED", "regularMarketChange": 0.038999796, "regularMarketTime": 1683910457, "regularMarketDayHigh": 3.324, "regularMarketDayRange": "3.23457 - 3.324", "regularMarketDayLow": 3.23457, "regularMarketVolume": 5077, "regularMarketPreviousClose": 3.265, "bid": 3.222, "ask": 3.386, "bidSize": 0, "askSize": 0, "fullExchangeName": "IOB", "financialCurrency": "USD", "regularMarketOpen": 3.292, "averageDailyVolume3Month": 6171, "averageDailyVolume10Day": 4383, "fiftyTwoWeekLowChange": 1.0119998, "fiftyTwoWeekLowChangePercent": 0.4415357, "fiftyTwoWeekRange": "2.292 - 5.445", "fiftyTwoWeekHighChange": -2.1410003, "fiftyTwoWeekHighChangePercent": -0.3932048, "fiftyTwoWeekLow": 2.292, "fiftyTwoWeekHigh": 5.445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.11, "sharesOutstanding": 93989696, "bookValue": 2.069, "fiftyDayAverage": 3.04398, "fiftyDayAverageChange": 0.26002002, "fiftyDayAverageChangePercent": 0.08542107, "twoHundredDayAverage": 3.288385, "twoHundredDayAverageChange": 0.015614986, "twoHundredDayAverageChangePercent": 0.0047485274, "marketCap": 317836544, "priceToBook": 1.5969067, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1388736000000, "priceHint": 4, "symbol": "0QAJ.IL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "177-181 Avenue Pierre Brossolette", "city": "Montrouge", "zip": "92120", "country": "France", "phone": "33 1 55 42 78 78", "fax": "33 1 43 26 10 83", "website": "https://www.dbv-technologies.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and eosinophilic esophagitis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestl\u00e9 Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.", "fullTimeEmployees": 85, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Tass\u00e9", "age": 62, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 1213805, "fmt": "1.21M", "longFmt": "1,213,805"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. S\u00e9bastien  Robitaille", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 335165, "fmt": "335.17k", "longFmt": "335,165"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pharis  Mohideen", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 725120, "fmt": "725.12k", "longFmt": "725,120"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pascal  Wotling", "title": "Chief Technical Operations Officer & Chief Quality Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Anne  Pollak", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Michele F. Robertson", "title": "Chief Legal Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Joseph  Becker", "title": "VP of Global Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Caroline  Daniere", "age": 47, "title": "Chief HR Officer & Chief of Staff", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Wence  Agbotounou", "title": "Chief Clinical Trial Officer & Sr. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edward P. Jordan M.B.A.", "age": 54, "title": "Sr. VP of Commercial Operations North America", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 1, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}